Sinopharm
1099.HK
#2032
Rank
โ‚น680.03 B
Marketcap
โ‚น217.91
Share price
-0.82%
Change (1 day)
-8.35%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚น5.089 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น6.984 Trillion. In 2022 the company made a revenue of โ‚น6.984 Trillion a decrease over the revenue in the year 2021 that were of โ‚น7.134 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น5.089 T-27.13%
2022 โ‚น6.984 T-2.1%
2021โ‚น7.134 T16.85%
2020โ‚น6.105 T14.95%
2019โ‚น5.311 T21.52%
2018โ‚น4.370 T5.93%
2017โ‚น4.125 T27.22%
2016โ‚น3.243 T5.37%
2015โ‚น3.077 T9.14%
2014โ‚น2.819 T17.22%
2013โ‚น2.405 T25.94%
2012โ‚น1.910 T34.61%
2011โ‚น1.419 T55.34%
2010โ‚น913.47 B35.79%
2009โ‚น672.72 B37.56%
2008โ‚น489.05 B31.43%
2007โ‚น372.11 B40.26%
2006โ‚น265.29 B